Ramin Oskoui
Cardiovascular Disease · Washington, DCNPI 1457306805
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,172 of the $15,305 with a category attached, or 66.5%. 31 manufacturers reported payments, led by Medtronic at 31.7% of the total. Reporting peaked in 2019 at $7,436 and has fallen 95.4% since, to $344 in 2023.
Across 414 payments — averaging $36.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boehringer Ingelheim$4K
- Pfizer$1K
- Amgen$597
- Novo Nordisk$591
- Novartis$560
- plus $4K from 25 others
What the payments were for
- Speaking & faculty fees$2,80518%
- Travel & lodging$1,97513%
- Food & beverage$10,17266%
- Education$3522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 105 | $4,854 |
| Boehringer Ingelheim | 28 | $3,630 |
| Pfizer | 38 | $1,134 |
| Amgen | 23 | $597 |
| Novo Nordisk | 13 | $591 |
| Novartis | 33 | $560 |
| Sanofi-aventis U.S. LLC | 33 | $488 |
| AstraZeneca | 12 | $465 |
| Esperion Therapeutics, Inc. | 15 | $461 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $324 |
| Amarin Pharma, Inc. | 19 | $313 |
| Merck | 15 | $312 |
| Johnson & Johnson | 9 | $246 |
| Edwards Lifesciences | 5 | $229 |
| E.r. Squibb & Sons, L.L.C. | 14 | $187 |
| Atricure, Inc. | 2 | $159 |
| Kowa Pharmaceuticals America, Inc. | 9 | $145 |
| Cvrx, Inc. | 1 | $140 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $100 |
| Bayer | 3 | $49 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Philips North America LLC | 2 | $34 |
| Kestra Medical Technology Services, Inc. | 1 | $33 |
| Penumbra, Inc. | 1 | $32 |
| Lundbeck LLC | 2 | $30 |
| Boston Scientific | 1 | $29 |
| Hikma Pharmaceuticals USA | 2 | $28 |
| Actelion Pharmaceuticals US, Inc. | 2 | $25 |
| Abbott | 1 | $22 |
| Portola Pharmaceuticals, LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRADAXA$2,912
- Claria MRI$583
- Ozempic$239
- JARDIANCE$204
- SelectSecure$193
- Micra$190
- MyCareLink$179
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$158
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$144
- Barostim Neo System$140
- ELIQUIS$136
- COMIRNATY$136
- Reveal LINQ$133
- FARXIGA$125
- Repatha$125
- NEXLIZET$115
- NEXLETOL$115
How this compares
$15,305 in reported general payments places this provider in the 85th percentile of 105 cardiovascular disease providers in District of Columbia.
See all cardiovascular disease providers in District of Columbia →
Other cardiovascular disease in Washington
- Hayder HashimWashington$824K
- Joshua YamamotoWashington$376K
- Mardi Gomberg-MaitlandWashington$320K
- Jaffar KhanWashington$318K
- Isaac Opoku-AsareWashington$146K
- Judith HsiaWashington$65K
- Ana BaracWashington$34K
- Jonathan PlehnWashington$32K
- Andrew ChoiWashington$32K
- Felton AndersonWashington$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.